LONGMONT, Colo.--(BUSINESS WIRE)--Chemizon, a division of OptoMagic Co. Ltd. (KOSDAQ: 010170), announced today that Takeda Pharmaceutical Company Limited will continue, and further expand its current research collaboration that utilizes Chemizon’s Discovery Platform. The expansion will be effective beginning the 1st of August, 2009.
